Q2i empowers healthcare teams with leading edge technology to improve the success of their Medication-Assisted Treatment (MAT) program.
Q2i’s solutions comprise healthcare team portals and patient mobile applications. We provide decision support software through data-rich, patient-centric, unified dashboards. Our technology includes predictive analytics (including AI and ML), telehealth and reward based solutions that increase patient engagement, adherence to treatment plans, connectedness and support, resulting in:
- Focus on at-risk patients
Outliers identified and patients managed by exception
- Timely interventions
Trending issues immediately flagged for attention
- Better outcomes
Improved ownership and adherence to treatment plans
100% Cloud, ready-to-go
Modern User Interface
Flexible and Scalable
Opioid Addiction Recovery Support is used by providers of MAT programs to improve insight into a patient’s recovery progress and promotes ownership and adherence to treatment plans. OARS also provides extensive tools to support patients with recovery from Opioid Use Disorder. Using OARS patients are better connected to, and supported by their healthcare team throughout their recovery journey.
This extended connection and support fosters conditions for:
CASA enables providers to regularly deliver educational and motivational content including reinforcement of relapse prevention strategies direct to the CASA powered mobile app.
The peer-to-peer messaging component helps build and maintain a network of sober friends with other alumni of the clinic and stay connected to others who relate to similar experiences and challenges.
Bari-Well empowers bariatric programs to better manage their patient populations. Bari-Well supports patients with pre and post surgery treatment plans in order to successfully achieve goals of long-term weight-loss.
Bari-Well provides useful tools to help providers manage and support their patients throughout all stages of the continuum of care.
To design, develop, and supply the most advanced technologies that empower healthcare teams to improve the success rate of their Medication-Assisted Treatment (MAT) programs.
To drive innovation, thereby increasing MAT program availability and access so that all Americans seeking recovery from Opioid Use Disorder can obtain the treatment they need.
Q2i collaborates with multidisciplinary healthcare teams, providers and payers to understand and then realize unmet technology needs. We facilitate improvements in patient care by supporting patients with their treatment plans through better connection and information exchange with their healthcare teams.
Q2i develops technology that assists health care providers in achieving the IHI quadruple aim of improving the patient experience of care (including quality and satisfaction), improving the health of populations, reducing the per capita cost of health care and improved clinician experience.
Medical Advisory Board
Q2i’s Medical Advisory Board provides in-depth subject matter expertise across a broad spectrum of healthcare delivery. This diverse composition provides a strong group dynamic providing insight and scientific direction. This ensures Q2i’s solutions not only improves patient outcomes and helps health systems and payers create value but that we go beyond traditional clinical efficacy to capture newer patient-focused considerations and impact the effectiveness and efficiency of care delivered under new value-based performance systems.
Gerald A. Kraines
M.D.Gerald A. Kraines, M.D. is a faculty member at Harvard Medical School.
Sara M. Bolton
M.D.Dr. Bolton is an assistant clinical professor of psychiatry at Harvard Medical School and an associate psychiatrist at McLean Hospital.
FRCSGuy is a consultant surgeon specializing in laparoscopic gastro-intestinal surgery and weight loss surgery.
PT, MSPT, OCS, Cert. MDTJeremy is a faculty member in the Department of Kinesiology and is the Director of the Nayden Rehabilitation Clinic.
Q2i in the News
1660 Soldiers Field Rd.
Brighton, MA 02135